Latest Content

Caroline Taylor discusses how disparities in access and resources affect diagnosis, treatment, and survival for patients globally.

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

A colon cancer survivor shares how practicing daily gratitude and journaling helped her find peace, healing and the strength to build a vibrant life.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.

Dr. Thomas Flaig discusses new therapies, biomarkers and evolving care strategies in an interview with CURE.

After a sudden collapse, a resilient cancer survivor faces a new health crisis. Through faith, PT and grit, she overcomes despair to walk again.

Dr. Sunil Dutta discusses treatment approaches and managing side effects in esophageal cancer, including nutrition and patient support strategies.

The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer, highlighting ongoing need for better first-line treatments.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

A tribute to Erin Cummings, a pillar of the Hodgkin lymphome survivor community who mentored others with the wisdom and grace of a real-life Mr. Miyagi.

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced recurrence risk.

A man with small cell lung cancer describes carboplatin-related hearing loss, fatigue and daily challenges that have reshaped his life, while holding onto perspective and resilience.

At NCCN 2026, Anjali Albanese discussed how young adults with cancer face grief, isolation and loss of control that impact their emotional well-being.